U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795203) titled 'Liposomal Bupivacaine vs Ropivacaine for Post-hemorrhoidectomy Analgesia' on Aug. 26.
Brief Summary: This is a single-center, prospective, randomized, double-blind controlled trial comparing the analgesic efficacy, quality of recovery, and safety of perianal wound infiltration with multivesicular liposomal bupivacaine (266 mg) versus ropivacaine hydrochloride (200 mg) in patients undergoing Milligan-Morgan open hemorrhoidectomy under spinal anesthesia. Both solutions are diluted to a total volume of 30 mL and infiltrated at six predefined perianal positions at the end of surgery. The primary outcome is the resting visual analog scal...